Evering TH - Search Results

1

Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System.

Evering TH, Tsuji M. Evering TH, et al. Front Immunol. 2018 Apr 4;9:649. doi: 10.3389/fimmu.2018.00649. eCollection 2018. Front Immunol. 2018. PMID: 29670623 Free PMC article. Review.

2

Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.

St Bernard L, Abolade J, Mohri H, Markowitz M, Evering TH. St Bernard L, et al. Among authors: evering th. J Virol. 2020 Sep 29;94(20):e01824-19. doi: 10.1128/JVI.01824-19. Print 2020 Sep 29. J Virol. 2020. PMID: 32759323 Free PMC article.

3

Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.

Evering TH. Evering TH. Curr HIV/AIDS Rep. 2018 Feb;15(1):72-83. doi: 10.1007/s11904-018-0374-3. Curr HIV/AIDS Rep. 2018. PMID: 29460224 Review.

4

Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.

Evering TH, Mehandru S, Racz P, Tenner-Racz K, Poles MA, Figueroa A, Mohri H, Markowitz M. Evering TH, et al. PLoS Pathog. 2012 Feb;8(2):e1002506. doi: 10.1371/journal.ppat.1002506. Epub 2012 Feb 2. PLoS Pathog. 2012. PMID: 22319447 Free PMC article.

5

Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.

Evering TH, Applebaum A, La Mar M, Garmon D, Dorfman D, Markowitz M. Evering TH, et al. AIDS. 2016 Jan;30(2):203-10. doi: 10.1097/QAD.0000000000000892. AIDS. 2016. PMID: 26684817 Free PMC article.

6

Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1.

Evering TH, Markowitz M. Evering TH, et al. Drugs Today (Barc). 2007 Dec;43(12):865-77. doi: 10.1358/dot.2007.43.12.1146063. Drugs Today (Barc). 2007. PMID: 18174972 Review.

7

A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals.

Markowitz M, Evering TH, Garmon D, Caskey M, La Mar M, Rodriguez K, Sahi V, Palmer S, Prada N, Mohri H. Markowitz M, et al. Among authors: evering th. J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):140-7. doi: 10.1097/QAI.0000000000000111. J Acquir Immune Defic Syndr. 2014. PMID: 24457632 Free PMC article. Clinical Trial.

8

Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.

Evering TH, Kamau E, St Bernard L, Farmer CB, Kong XP, Markowitz M. Evering TH, et al. Retrovirology. 2014 Aug 15;11:65. doi: 10.1186/s12977-014-0065-0. Retrovirology. 2014. PMID: 25125210 Free PMC article.

9

Raltegravir: an integrase inhibitor for HIV-1.

Evering TH, Markowitz M. Evering TH, et al. Expert Opin Investig Drugs. 2008 Mar;17(3):413-22. doi: 10.1517/13543784.17.3.413. Expert Opin Investig Drugs. 2008. PMID: 18321239 Review.

10

Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.

Markowitz M, Deren S, Cleland C, La Mar M, Silva E, Batista P, St Bernard L, Gettie N, Rodriguez K, Evering TH, Lee H, Mehandru S. Markowitz M, et al. Among authors: evering th. J Infect Dis. 2016 Nov 1;214(9):1376-1382. doi: 10.1093/infdis/jiw373. Epub 2016 Aug 11. J Infect Dis. 2016. PMID: 27521361 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page